-
9 drugs out of sale: acetaminophen tablets, gold and silver flower dew
Time of Update: 2020-11-01
Of the 9 unqualified drugs, 5 are preparations, namely, Dragon Tiger Dan, acetaminophen tablets, gold and silver flower dew, glucose injections, silver tablets; notice, the relevant drug regulatory departments at all levels have asked relevant enterprises to take risk control measures such as suspension and suspension, and investigate and punish them in accordance with the law.
-
Medical devices rose the most in June, the future industry is expected to enter a golden age
Time of Update: 2020-07-16
Pharmaceutical Network Market Analysis: The medical device industry is related to human health and life safety, is a multidisciplinary, knowledge-intensive, capital-intensive high-tech industry, but
-
Ono Launches Demser250mg Capsules in Japan for Treatment of Patients with Chromoblastoma
Time of Update: 2020-06-10
chromosomal cell tumor (PC) is a neuroendocrine tumor that originates in the adrenal myelin or the peripheral nerve section of the adrenal gland, with an estimated 2,920 patients in Japan recently,
-
The pharmaceutical sector led the rise, the strength can continue for how long
Time of Update: 2020-04-27
Pharmaceutical Network Pharmaceutical Stock Market, investment side, in the A-share major theme industries, the pharmaceutical sector led the rise, the income is quite rich According to the data, the
-
What does China's pharmaceutical enterprises rely on to win market voice
Time of Update: 2020-03-06
Pharmaceutical Network Market Analysis in recent years, the pharmaceutical industry has been rapid development, the industry said that the overall development trend of the pharmaceutical industry in
-
The energy-saving effect of domestic drug machine is beginning to show, and the future development needs to break through two major bottlenecks
Time of Update: 2020-02-27
Pharmaceutical Network Market Analysis: Speeding up the industrialization of energy-saving technology and equipment is an important measure to enhance the energy-saving ability of the whole society a
-
Global innovation! Sansheng pharmaceutical is authorized by the new target of immunotherapy PSGL-1 mAb, reprogramming macrophages to stimulate synergistic antitumor response
Time of Update: 2019-11-18
November 18, 2019 / BIOON / - sansbio pharmaceutical and Verseau therapeutics announced today that according to the cooperation agreement on the development and commercialization of innovative monoclo
-
Rough marketing has become the future of "4 + 7" era how to play a good compliance marketing war
Time of Update: 2019-10-30
In recent years, the media reported "Sanofi China disbands the Plavix medical team" and "Beijing Jialin pharmaceutical agent disbands the sales team" Later, Sanofi issued a statement saying that the m
-
The future opportunities of the pharmaceutical industry are still optimistic. It is recommended to pay attention to these pharmaceutical enterprises
Time of Update: 2019-10-22
[trends of pharmaceutical network industry] since the second half of this year, influenced by the policies of 4 + 7 volume procurement nationwide expansion, the internal pattern of the pharmaceutical
-
90 drugs are required to be reported at the national low price, including key monitored varieties
Time of Update: 2019-09-04
[industry trends of pharmaceutical network] on September 2, Qinghai provincial centralized purchasing network of drugs and medical consumables released the notice on filling in the national low price
-
Fuhong Hanlin has invested 70 million yuan in clinical trials of new drugs for gastric cancer and breast cancer
Time of Update: 2019-02-13
Fosun Pharmaceutical announced in the afternoon of February 12 that its holding subsidiaries Fuhong Hanlin and Hanlin pharmaceutical had recently received the approval from the State Drug Administrati
-
Erkang pharmaceutical expects the highest decline of net profit of 60% in 2018, and cancels over 250 million purchase and sale contracts
Time of Update: 2019-01-31
On January 30, the "2018 annual performance forecast" released by Erkang pharmaceutical showed that the expected net profit was RMB 208982500-313473800, down 40% - 60% year on year There are three mai
-
How are pharmaceutical companies doing when the environmental protection tax comes
Time of Update: 2018-04-03
[China Pharmaceutical network industry trends] on January 1, 2018, China's first environmental protection tax law was officially implemented This tax law is the first single tax law in China that embo
-
In 2017, China's top 20 western medicine export companies were born
Time of Update: 2018-04-03
[China Pharmaceutical network enterprise news] the author understands that in 2017, China's pharmaceutical exports reached US $3.456 billion, an increase of 8.32% year on year Recently, the list of to
-
Cao Xiaojun: the key to drug sales is to improve professional service level
Time of Update: 2017-08-29
[expert opinion of chinapharma.com] Cao Xiaojun, vice general manager of CIIC Pharmaceutical Group, expounded his views on how to break the hot sales of categories and how to provide good health servi
